Cannabinoid Actives | DSM Pharma Solutions

HIGH-QUALITY PRODUCTS

Develop next generation pharmaceuticals

The science behind cannabinoids, like cannabidiol (CBD), is growing rapidly – with research demonstrating the potential of these molecules to support a wide range of health areas that could benefit patients with conditions including CNS (central nervous system) diseases,¹ pain disorders,² cancer³ and more. This is creating a myriad of opportunities for innovation across the pharmaceutical industry and inspiring the development of bespoke drug products that will support global patient health.

We’ve created an innovation platform that facilitates agile early-stage drug development and novel scientific discoveries in this new and promising field. Our offering includes:

High-quality, THC-free CBD active pharmaceutical ingredient
Access to leading minor cannabinoid actives and supporting clinical data
Customized solutions, including formulation and technical capabilities
Regulatory, quality and scientific expertise

References

Ożarowski, M., Karpiński, T. M., Zielińska, A., Souto, E. B., & Wielgus, K. (2021). Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action. International journal of molecular sciences, 22(9), 4294. https://doi.org/10.3390/ijms22094294
Argueta, D. A., Ventura, C. M., Kiven, S., Sagi, V., & Gupta, K. (2020). A Balanced Approach for Cannabidiol Use in Chronic Pain. Frontiers in pharmacology, 11, 561. https://doi.org/10.3389/fphar.2020.00561
O'Brien K. (2022). Cannabidiol (CBD) in Cancer Management. Cancers, 14(4), 885. https://doi.org/10.3390/cancers14040885

Looking for more information?

Download our brochure to unlock the potential of cannabinoid-based innovation and learn more about how DSM can help you enter the market with confidence.

Download our brochure

Explore our Cannabinoid APIs

Optimizing CBD formulations

Experts insights

CBD for nutritional solutions

Connect with an expert

Explore the science-based benefits behind CBD

It is an exciting time for pharmaceutical researchers and developers with 200+ clinical trials exploring the therapeutic capacity of CBD and an increasing bank of evidence demonstrating the promising potential of the molecule.

Download our whitepaper to explore the latest science behind CBD and discover your next opportunity in early-stage drug development.

CANNABINOID APIS

Optimizing CBD formulations: discover the benefits of using lipid-based systems

This whitepaper explores the challenges surrounding the oral bioavailability of CBD and the benefits of using lipid-based systems in your formulation. Unlock novel opportunities in the CBD space.

Download whitepaper

Get an expert perspective on cannabinoids

CBD in the medical care toolbox of practitioners to treat patients - where are we today?

Ask-the-Expert: CBD and lipids - a winning combination for CBD-based innovation

Watch video

The promising potential of CBD in the management of chronic pain

Watch video

What role can medical CBD play in supporting mental health? Get an expert's perspective

Watch video

CBD FOR MENTAL HEALTH

Webinar: Is CBD a potential therapy for mental health disorders?

Watch our latest webinar held in partnership with Manufacturing Chemist and join Professor José Alexandre de Souza Crippa, Department of Neurosciences and Behaviour, University of São Paulo, Brazil, and Dr Mariana Coelho, Clinical Project Scientist at DSM, as they discuss the latest science and promising research into whether cannabidiol is a potential therapy to treat patients suffering from mental health conditions.

CBD FOR NUTRITIONAL SOLUTIONS

Discover innovation opportunities in the nutrition market

CBD is set to disrupt the dietary supplement category, driven by strong consumer interest in the ingredient’s possible benefits for immunity, stress, mood, sleep and more. Learn about our CBD offering for the nutrition market and how we’re supporting customers develop health benefit-driven products – from concept to consumer – with market-ready and premix solutions.

Find out more